Tolvaptan HCl Tablets

The main use of this product is in colon cancer, in particular, in combination with other chemotherapy agents.

Strength: 40mg/2ml; 100mg/5ml.

NMPA approved.
MA issued from US-FDA, Japanese PMDA.

Letrozole is an oral non-steroidal aromatase inhibitor for the treatment of hormonally-responsive breast cancer after surgery.

Strength: 2.5mg.

Letrozole Tablets is approved by NMPA and EU GMP (Spain and  Netherlands), and have MA issued from US-F...

Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

Strength: 50mg/vial.

It is the first injection product of domestic pharmaceutical enterprises approved to get launched in the European market.
MA issued from Spain, Netherlands CBG and UK MH...

Fondaparinux is an anticoagulant medication chemically related to low molecular weight heparins.
Strength: 0.5ml:2.5mg; 0.4ml:0.5mg; 0.6ml:7.5mg; 0.8ml:10mg.

It is approved by US-FDA.

Thiotepa for Injection USP is an alkylating agentused to treat cancer.

Strength: 15mg/vial

Approved by US-FDA.
Dossiers for EU market have been filed.

It is a kind of contrast agent.

Strength: 
(300mg iodine/ml) 61% *50ml *100ml  
(370mg iodine/ml) 76% *50ml *100ml *150ml *200ml


It is in R&D stage.

Oxaliplatin is a platinum-based antineoplastic agent used in cancerchemotherapy.

Strength: 50mg/10ml; 100mg/20ml.


NMPA approved; MA issued from US-FDA.

It is an orally-administered chemotherapeutic agent used in the treatment of numerous cancers. It is a prodrug that is enzymatically converted to 5-fluorouracil (5-FU) in the body.

Strength: 150mg; 500mg

CFDA approved.

US-AN...

It is a medication used mainly for chemotherapy and sometimes for immunosuppression before organ transplantation. It is used in the treatment of several types of brain cancer (including glioma, glioblastoma multif...

Daptomycin is a lipopeptide antibiotic used in the treatment of systemic and life-threatening infections caused by Gram-positive organisms.

Strength: 500mg/vial.


This product has been approved by NMPA in 2016.

It is approved by US-FDA.

It is used to outline structures in radiological investigations. It is used in chemoembolization applications as a contrast agent in follow-up imaging. It is also used in lymphangiography, the imaging of the lymphatic system. It has an additional use in gastric variceal obl...

Iodixanol is a contrast agent commonly used duringcoronary angiography.

This product has been approved by NMPA.


Strength: 320mgI/ml (100ml)
Iodixanol Injection USP (Packaged in PP bottles)---Strength: 320mgI/ml (50ml; 100ml; 150ml; 200ml)

Approve...

Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.

For APIs, we got approvals from US-FDA, EDQM, PMDA and TGA.

For FDFs, we got approvals from US-FDA, EU and PMDA.